Charlton Kevin M. sold (to issuer) 67,500 shares of EVLV

Charlton Kevin M. sold (to issuer) 67,500 shares of Evolv Technologies Holdings, Inc. (EVLV) on 2026-07-16.

Original reporting
SEC EDGAR · Charlton Kevin M.
Published Oct 6, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVLV
Neutral
medium confidence
Mentioned
$EVLV
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVLVNeutralLow
01

Why it matters

The director's sale of 67,500 shares may be interpreted as a mild bearish signal, but the lack of price details and modest size reduce material impact.

02

Market read

Primary relevance is to EVLV shareholders; broader market effect is limited.

03

What to watch

Absence of price and total value limits assessment; potential upcoming corporate actions not disclosed.

Relevance 4/10Novelty 4/10Timing: filing date today

Background

SEC Form 4 filings disclose insider transactions, providing transparency on insider buying or selling activity.

Company-level read

Ticker impact

$EVLVNeutralMedium confidence
Context

Director Charlton Kevin M. sold 67,500 shares of Evolv Technologies Holdings, Inc. (EVLV) in a Form 4 filing dated 2026-07-16.

Expected impact

possible slight pressure as the market absorbs the insider sell

Evidence & confidence

Director sales often weigh on sentiment, yet the lack of price information and modest share count limit the expected move.

Market effects

Minimal impact on the broader AI/tech sector; the filing is company‑specific.

None

None

Counterpoint

The sale could be routine portfolio rebalancing and not indicative of future performance.

Key entities

  • Evolv Technologies Holdings, Inc.

    Publicly traded AI/technology firm (ticker EVLV).

  • Charlton Kevin M.

    Director of Evolv Technologies Holdings, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBMed

Selling Some Rocket Lab After Launch Record

Rocket Lab (RKLB) achieved its 100th Electron launch, deploying a satellite for iQPS. Goldman Sachs raised its target price to $68. ULA's Vulcan rocket failed, destroying Amazon's (AMZN) satellites, halting launches. Analysts adjusted targets for Ondas Inc (ONDS). Peloton (PTON) launched a cheaper treadmill, the Tread Flex, aiming to boost affordability.

$EVLVMed

Evolv Technology Reports Third Quarter Financial Results

Evolv Technologies Holdings, Inc. (EVLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Evolv Technology Reports Third Quarter Financial Results • Q3'26 Revenue of $47.3 million, up 10% year-over-year • Q3'26 Ending ARR 1 of $140.5 million, up 20% year-over-year • Q3'26 Net Loss of $(15.6) million, with Net Profit Margin of (32.9)% • Q3'26 Adjusted EBIT

$EVLVMed

Evolv Technologies Holdings, Inc. Q2 2026 Earnings Call Summary

Evolv Technologies Holdings reported 34% Q2 2026 revenue growth, citing new customer acquisition and completion of a direct fulfillment transition. Management raised full-year 2026 revenue guidance to 23% to 27% growth, expects over 10,000 units deployed by year-end, and remains cash-flow positive while potentially investing $2m to $4m in inventory safety stock.

$EVLVHigh

Evolv Technology Reports Second Quarter Financial Results

Evolv Technologies Holdings, Inc. (EVLV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Evolv Technology Reports Second Quarter Financial Results — Company Adds 70 New Customers — — Company Raises Growth Estimates for 2026 — • Q2'26 Revenue of $43.8 million, up 34% year-over-year • Q2'26 Ending ARR 1 of $132.7 million, up 20% year-over-year • Q2'26 Net